Amundi
GILD icon

Amundi’s Gilead Sciences GILD Stock Holding History

Amundi’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23B Sell
9,772,438
-766,673
-7% -$101M 0.3% 59
2026
Q1 		$1.47B Buy
10,539,111
+1,018,976
+11% +$143M 0.4% 43
2025
Q4 		$1.17B Buy
9,520,135
+1,936,354
+26% +$235M 0.32% 66
2025
Q3 		$861M Sell
7,583,781
-2,883,630
-28% -$328M 0.28% 70
2025
Q2 		$1.17B Buy
10,467,411
+1,614,355
+18% +$172M 0.4% 47
2025
Q1 		$995M Sell
8,853,056
-167,143
-2% -$17.2M 0.36% 54
2024
Q4 		$805M Sell
9,020,199
-4,596,188
-34% -$414M 0.28% 78
2024
Q3 		$1.16B Buy
13,616,387
+2,375,858
+21% +$181M 0.43% 46
2024
Q2 		$751M Buy
11,240,529
+1,739,913
+18% +$116M 0.29% 75
2024
Q1 		$640M Sell
9,500,616
-1,019,938
-10% -$78.4M 0.28% 83
2023
Q4 		$896M Sell
10,520,554
-82,104
-0.8% -$6.39M 0.4% 47
2023
Q3 		$818M Sell
10,602,658
-316,824
-3% -$24.4M 0.4% 45
2023
Q2 		$838M Buy
10,919,482
+294,400
+3% +$23.5M 0.42% 42
2023
Q1 		$888M Buy
10,625,082
+437,302
+4% +$36.2M 0.48% 38
2022
Q4 		$886M Sell
10,187,780
-21,368
-0.2% -$1.69M 0.49% 35
2022
Q3 		$659M Buy
10,209,148
+2,126,205
+26% +$134M 0.39% 45
2022
Q2 		$500M Buy
8,082,943
+1,267,513
+19% +$78.5M 0.4% 52
2022
Q1 		$412M Sell
6,815,430
-4,123,846
-38% -$264M 0.28% 92
2021
Q4 		$788M Buy
10,939,276
+495,760
+5% +$34.1M 0.5% 39
2021
Q3 		$729M Buy
10,443,516
+1,617,865
+18% +$114M 0.51% 36
2021
Q2 		$608M Buy
+8,825,651
New +$589M 0.42% 47

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Amundi's GILD Position: Q2 2026 in Review

Amundi reduced its Gilead Sciences (GILD) stake by 7.3% in Q2 2026, selling an estimated $101M and leaving 9,772,438 shares worth $1.23B. The position accounts for 0.3% of the portfolio, ranked #59.

Amundi first reported a position in GILD in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.47B in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Amundi held 9,772,438 shares of Gilead Sciences worth $1.23B as of Q2 2026.
  • Amundi sold 766,673 Gilead Sciences shares in Q2 2026, an estimated $101M.
  • Gilead Sciences made up 0.3% of Amundi's portfolio in Q2 2026, its #59 holding.
  • Amundi first reported a position in Gilead Sciences in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Gilead Sciences position peaked at $1.47B in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.